SCHEMBL647493

SCHEMBL647493

CC(C)(C)OC(=O)N1CCC(O)(C(c2ccc(OC(F)(F)F)cc2)c2ccc(OC(F)(F)F)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.52
LIPE Q05469 1/20 0.46
EPHX2 P34913 3/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
ATM Q13315 1/20 0.41
P2RX7 Q99572 1/20 0.41
ALDH1A1 P00352 3/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 2/20 0.41
KCNH2 Q12809 1/20 0.40
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40
ABHD6 Q9BV23 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5012790 0.84 SLC6A2 (0.44) EPHX2SLC6A2SLC6A4HRH3
SCHEMBL3396946 0.82 GPR119 (0.54) GPR119LIPEEPHX2SLC6A4ATM
SCHEMBL3955520 0.81 GPR119 (0.50) GPR119LIPEEPHX2SLC6A2SLC6A4
SCHEMBL3955967 0.81 GPR119 (0.49) GPR119LIPESLC6A2SLC6A4P2RX7
SCHEMBL4236846 0.77 GPR119 (0.57) GPR119LIPEEPHX2ALDH1A1NPC1
SCHEMBL30482767 0.76 GPR119 (0.51) GPR119LIPEEPHX2ABHD6
SCHEMBL2779904 0.76 MEN1 (0.52) GPR119LIPEEPHX2KCNH2SCN5A
SCHEMBL2778389 0.76 SLC6A4 (0.58) GPR119LIPEEPHX2SLC6A4KCNH2
SCHEMBL24485515 0.75 MAPT (0.51) GPR119ATMALDH1A1NPC1MAPT
SCHEMBL3922515 0.75 LMNA (0.61) GPR119LIPEALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119563-B2 N-substituted azacycles FMC CORPORATION (US) 2012-02-21 US disclosed
US-20090215821-A1 N-Substituted Azacycles FMC CORPORATION 2009-08-27 US disclosed
EP-1673083-A4 N-SUBSTITUTED AZACYCLES BAYER CROPSCIENCE AG (DE) 2008-12-17 EP disclosed
EP-1673083-A2 N-SUBSTITUTED AZACYCLES FMC CORPORATION (US) 2006-06-28 EP disclosed
WO-2005036961-A2 N-SUBSTITUTED AZACYCLES FMC CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215821-A1 N-Substituted Azacycles DDT, UQCRB, DNMT1 GPR119 777/4885LIPE 2683/4885EPHX2 1495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.